Literature DB >> 22901352

Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.

Xiang Yang Zhang1, Da Chun Chen, Mei Hong Xiu, Fu De Yang, Colin N Haile, Therese A Kosten, Thomas R Kosten.   

Abstract

BACKGROUND: Schizophrenia shows gender differences in patients' clinical presentation, neurocognitive impairment, course, and treatment outcome. The aims of this study were to compare gender differences in clinical features and cognitive functioning in first-episode and chronic schizophrenia among Han Chinese inpatients.
METHOD: We compared gender differences in 262 unmedicated first-episode schizophrenia and 960 chronic schizophrenia inpatients (diagnosed according to DSM-IV) to 804 matched healthy controls on sociodemographic characteristics, smoking behavior, and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Patients were also rated on the Positive and Negative Syndrome Scale. The study was conducted from December 2006 to May 2008.
RESULTS: Schizophrenia first occurred in both first-episode and chronic schizophrenia patients at a significantly earlier age in male than female patients (P < .05 and P < .001, respectively). The paranoid subtype of schizophrenia was more common in female patients only in chronic schizophrenia, not first-episode patients. Further, cigarette smoking was more common in male than female patients from both patient groups, and, among men, more chronic schizophrenia patients than controls smoked, while among women, fewer chronic schizophrenia patients than controls smoked. Female chronic schizophrenia patients had more severe positive and general psychopathological symptoms, whereas male patients had more severe negative symptoms. By contrast, first-episode schizophrenia patients showed no gender differences in symptoms and severity. Both first-episode and chronic schizophrenia patients performed worse than controls on most of the cognitive tasks. RBANS attention, delayed memory, and immediate memory were less impaired in female than male chronic schizophrenia patients, and first-episode schizophrenia patients showed no gender differences.
CONCLUSIONS: Chronic schizophrenia patients have notable gender differences in the age at onset, smoking, symptom severity, and cognitive function favoring women, but first-episode schizophrenia patients show few gender differences. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901352     DOI: 10.4088/JCP.11m07422

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  27 in total

Review 1.  The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Neuropsychopharmacology       Date:  2015-08-07       Impact factor: 7.853

2.  Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Authors:  Ke Xu; John H Krystal; Yuping Ning; Da Chun Chen; Hongbo He; Daping Wang; Xiaoyin Ke; Xifan Zhang; Yi Ding; Yuping Liu; Ralitza Gueorguieva; Zuoheng Wang; Diana Limoncelli; Robert H Pietrzak; Ismene L Petrakis; Xiangyang Zhang; Ni Fan
Journal:  J Psychiatr Res       Date:  2014-12-24       Impact factor: 4.791

Review 3.  Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?

Authors:  Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

4.  Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis.

Authors:  Gabriella Buck; Katie M Lavigne; Carolina Makowski; Ridha Joober; Ashok Malla; Martin Lepage
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

5.  Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.

Authors:  Fang Yang; Keming Wang; Xiangdong Du; Huiqiong Deng; Hanjing Emily Wu; Guangzhong Yin; Yuping Ning; Xingbing Huang; Antonio L Teixeira; João de Quevedo; Jair C Soares; Xiaosi Li; XiaoE Lang; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2018-11-19       Impact factor: 4.530

6.  Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.

Authors:  Jing Qin Wu; Da Chun Chen; Yun Long Tan; Shu Ping Tan; Li Hui; Men Han Lv; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-07-04       Impact factor: 4.530

7.  Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Authors:  Leah H Rubin; Jessica J Connelly; James L Reilly; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; Anthony C Ruocco; Sarah K Keedy; Ian Matthew; Neeraj Tandon; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Elliot S Gershon; Matcheri S Keshavan; Jeffrey R Bishop; John A Sweeney
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2015-11-09

Review 8.  Maternal stressors and the developmental origins of neuropsychiatric risk.

Authors:  Seva G Khambadkone; Zachary A Cordner; Kellie L K Tamashiro
Journal:  Front Neuroendocrinol       Date:  2020-02-18       Impact factor: 8.606

Review 9.  Sex differences in stress reactivity in arousal and attention systems.

Authors:  Debra A Bangasser; Samantha R Eck; Evelyn Ordoñes Sanchez
Journal:  Neuropsychopharmacology       Date:  2018-06-29       Impact factor: 7.853

10.  Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia.

Authors:  Anna Tkachev; Elena Stekolshchikova; Nickolay Anikanov; Svetlana Zozulya; Aleksandra Barkhatova; Tatiana Klyushnik; Daria Petrova
Journal:  Biomolecules       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.